Skip to search formSkip to main contentSkip to account menu

Schindler Disease, Type II

Known as: Alpha-N-acetylgalactosaminidase deficiency type 2, NAGA Deficiency, Type II, ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
RATIONALE Schindler disease is caused by the deficient activity of α-N-acetylgalactosaminidase, which leads to an abnormal… 
2013
2013
Rationale: Visceral adipose tissue-derived serine proteinase inhibitor (vaspin) is an adipokine identified from visceral adipose… 
2013
2013
In-Ga-Zn-O thin films formed by a sputtering method, in which distinct crystallinity was not observed by selected area electron… 
2012
2012
Schindler/Kanzaki disease is an inherited metabolic disease with no current treatment options. This neurologic disease results… 
Highly Cited
2011
Highly Cited
2011
Background: The degradation pathway of the intestinal mucin by bifidobacteria is poorly understood. Results: A novel α-N… 
2006
2006
Summaryα-N-Acetylgalactosaminidase deficiency is a lysosomal disorder with clinically very different infantile and adult forms… 
2005
2005
SummaryA new lysosomal storage disease with autosomal recessive inheritance is described in two male siblings of 5 1/2 and 4… 
2004
2004
An α-N-acetylgalactosaminidase IV able to remove blood type specificity of human A(II)-erythrocytes and not effecting B(III…